John C.k. Milligan IV, President/Secretary at TherapeuticsMD, Inc. (TXMD), sold 258,000 shares at $4.98 ($1.2M) on 2018-12-04, disclosed to the SEC on 2018-12-06.
Open-market sale of $1.2M TXMD by President/Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.98 | 129,000 | $642K | 52.1% |
| 2 | $4.57 | 129,000 | $590K | 47.9% |
| Total | $4.78 avg | 258,000 | $1.2M | 100% |
| Filing → |
| TXMD | BUY | 2019-08-19 | $29K | — | Filing → |
| TXMD | BUY | 2019-08-14 | $47K | — | Filing → |
| TXMD | SELL | 2018-12-19 | $1.4M | — | Filing → |